March 2023
1. HERNANDEZ-GONZALEZ M, Calcraft T, Nans A, Rosenthal PB, et al
   A succession of 2 viral lattices drives vaccinia virus assembly.
   PLoS Biol. 2023;21:e3002005.
   

   >> Share

   
   September 2022
2. DAY T, Kennedy DA, Read AF, Gandon S, et al
   Pathogen evolution during vaccination campaigns.
   PLoS Biol. 2022;20:e3001804.
   

   >> Share

   
   
3. KOEKEN VACM, Qi C, Mourits VP, de Bree LCJ, et al
   Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination.
   PLoS Biol. 2022;20:e3001765.
   

   >> Share

   
   May 2022
4. ZHU DY, Gorman MJ, Yuan D, Yu J, et al
   Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.
   PLoS Biol. 2022;20:e3001609.
   

   >> Share

   
   
5. LU-CULLIGAN A, Tabachnikova A, Perez-Then E, Tokuyama M, et al
   No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.
   PLoS Biol. 2022;20:e3001506.
   

   >> Share

   
   
6. SYENINA A, Gan ES, Toh JZN, de Alwis R, et al
   Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes.
   PLoS Biol. 2022;20:e3001643.
   

   >> Share

   
   April 2022
7. NUISMER SL
   One step closer to a transmissible vaccine for rabies virus.
   PLoS Biol. 2022;20:e3001607.
   

   >> Share

   
   
8. GRIFFITHS ME, Broos A, Bergner LM, Meza DK, et al
   Longitudinal deep sequencing informs vector selection and future deployment strategies for transmissible vaccines.
   PLoS Biol. 2022;20:e3001580.
   

   >> Share

   
   December 2021
9. AMANAT F, Strohmeier S, Meade P, Dambrauskas N, et al
   Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus.
   PLoS Biol. 2021;19:e3001384.
   

   >> Share

   
   November 2021
10. KESSIE DK, Rudel T
    Advanced human mucosal tissue models are needed to improve preclinical testing of vaccines.
    PLoS Biol. 2021;19:e3001462.
    

    >> Share

    
    
11. MURUATO A, Vu MN, Johnson BA, Davis-Gardner ME, et al
    Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
    PLoS Biol. 2021;19:e3001284.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share